SQSTM1 and Alzheimer disease: Additionally, targeting autophagy receptors such as Optineurin (OPTN) and Sequestosome 1 (SQSTM1) can increase bone density and strength in AD mice, promote Aβ clearance, and maintain bone homeostasis [210].